Active, not recruitingNCT06594705

JENA-VAD

The JenaValve ALIGN-AR LVAD Registry

JenaValve Technology, Inc.Multiple US sitesView on ClinicalTrials.gov

AI Description

To evaluate the safety and effectiveness of the JenaValve Trilogy™ Heart Valve System for transcatheter aortic valve replacement (TAVR) in subjects with continuous flow left ventricular assist devices (cfLVAD) and clinically significant aortic regurgitation (AR) who are indicated for TAVR

Report inaccurate information

Who can join
adult, older adult
Participants
50
Expected completion
2027-08
Funded by
industry

Conditions studied

Aortic Insufficiency, Aortic Regurgitation, Aortic Valve Disease, Aortic Valve Insufficiency, Left Ventricular Dysfunction

What is being tested

  • DEVICE: JenaValve Trilogy Heart Valve System

What it measures

  • Acute Kidney Injury, Number of patients that had acute kidney injury (AKI) stage 3 or 4, 30 days
  • All Stroke, Number of patients that had stroke, 30 days
  • All-cause mortality, All-cause mortality within the first 30 days post index procedure, 30 days
  • Bleeding, Freedom from VARC type 2-4 bleeding, 30 days
  • Device Performance, Intended performance of the valve (i.e., no moderate or severe prosthetic valve regurgitation)\*, 30 days
  • Device Positioning, Freedom from incorrect positioning of a single prosthetic heart valve into the proper anatomical location, 30 days
  • Device Success, Freedom from unsuccessful delivery of the device, and retrieval of the delivery system, 30 days
  • Major Vascular Complication, Number of patients that had major vascular, access-related, or cardiac structural complication, 30 days
  • Permanent pacemaker implantation, Number of patients that had these events, 30 days
  • Surgery/intervention related to device, Freedom from surgery or intervention related to the device# or to a major vascular or access-related or cardiac structural complication, 30 days
  • Total aortic regurgitation, Number of patients that had moderate or severe total aortic regurgitation, 30 days

Centers Participating

These centers are participating in this study. Reach out to them directly to learn more.

Data Sources and Methodology

Registry entry updated 2026-07-22

Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.

If you would rather we did it with you, call us on (656) 206-4686.